Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Deficiency Syndromes | 16 | 2024 | 201 | 3.330 |
Why?
|
DiGeorge Syndrome | 8 | 2023 | 79 | 1.800 |
Why?
|
Thymus Gland | 8 | 2013 | 100 | 1.740 |
Why?
|
Genetic Testing | 5 | 2021 | 996 | 1.680 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 145 | 1.120 |
Why?
|
Killer Cells, Natural | 8 | 2024 | 320 | 1.070 |
Why?
|
Severe Combined Immunodeficiency | 5 | 2018 | 105 | 0.870 |
Why?
|
Mutation | 17 | 2025 | 5767 | 0.780 |
Why?
|
RGS Proteins | 1 | 2021 | 47 | 0.750 |
Why?
|
Parathyroid Glands | 2 | 2011 | 28 | 0.720 |
Why?
|
Phenotype | 12 | 2025 | 4226 | 0.700 |
Why?
|
Body Height | 1 | 2021 | 210 | 0.690 |
Why?
|
Transplantation Tolerance | 2 | 2010 | 15 | 0.650 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2020 | 862 | 0.580 |
Why?
|
Herpesvirus 4, Human | 3 | 2021 | 663 | 0.540 |
Why?
|
Cytomegalovirus | 1 | 2018 | 269 | 0.530 |
Why?
|
Sirolimus | 1 | 2018 | 220 | 0.520 |
Why?
|
T-Lymphocyte Subsets | 4 | 2016 | 195 | 0.520 |
Why?
|
Transplantation, Homologous | 5 | 2011 | 659 | 0.520 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 340 | 0.510 |
Why?
|
Cytomegalovirus Infections | 2 | 2018 | 217 | 0.510 |
Why?
|
Genomics | 3 | 2022 | 1474 | 0.500 |
Why?
|
Granulomatous Disease, Chronic | 3 | 2020 | 65 | 0.490 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2018 | 289 | 0.480 |
Why?
|
Alleles | 8 | 2025 | 1603 | 0.470 |
Why?
|
Gain of Function Mutation | 4 | 2018 | 105 | 0.470 |
Why?
|
Genetic Predisposition to Disease | 7 | 2020 | 3076 | 0.460 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 367 | 0.440 |
Why?
|
Haploinsufficiency | 3 | 2023 | 247 | 0.430 |
Why?
|
Humans | 65 | 2025 | 123120 | 0.420 |
Why?
|
B-Lymphocytes | 6 | 2025 | 518 | 0.420 |
Why?
|
Genome, Human | 2 | 2025 | 1264 | 0.410 |
Why?
|
Lymphatic System | 1 | 2012 | 20 | 0.400 |
Why?
|
Infant | 20 | 2025 | 12357 | 0.370 |
Why?
|
Agammaglobulinemia | 2 | 2021 | 39 | 0.370 |
Why?
|
STAT1 Transcription Factor | 3 | 2025 | 69 | 0.350 |
Why?
|
Carrier Proteins | 3 | 2021 | 1017 | 0.340 |
Why?
|
Actins | 2 | 2024 | 341 | 0.340 |
Why?
|
Immunophenotyping | 5 | 2018 | 328 | 0.330 |
Why?
|
Lymphoproliferative Disorders | 2 | 2021 | 224 | 0.320 |
Why?
|
Common Variable Immunodeficiency | 2 | 2020 | 26 | 0.310 |
Why?
|
Membrane Proteins | 3 | 2020 | 1522 | 0.290 |
Why?
|
Genetic Association Studies | 6 | 2021 | 760 | 0.290 |
Why?
|
Heterozygote | 5 | 2025 | 678 | 0.280 |
Why?
|
Child, Preschool | 17 | 2025 | 13888 | 0.270 |
Why?
|
Autoimmune Diseases | 2 | 2019 | 250 | 0.270 |
Why?
|
Male | 32 | 2025 | 60140 | 0.250 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2023 | 1199 | 0.240 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 475 | 0.240 |
Why?
|
Aging | 1 | 2012 | 1176 | 0.240 |
Why?
|
Female | 31 | 2025 | 65527 | 0.240 |
Why?
|
Penetrance | 1 | 2025 | 103 | 0.230 |
Why?
|
Child | 20 | 2025 | 24228 | 0.230 |
Why?
|
Hypersensitivity | 2 | 2024 | 182 | 0.230 |
Why?
|
Dermatitis | 1 | 2024 | 25 | 0.230 |
Why?
|
Neutropenia | 2 | 2022 | 202 | 0.220 |
Why?
|
Phospholipase C gamma | 1 | 2023 | 17 | 0.220 |
Why?
|
Pedigree | 7 | 2021 | 1576 | 0.220 |
Why?
|
Disease Management | 2 | 2018 | 514 | 0.220 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 22 | 0.210 |
Why?
|
Nuclear Proteins | 3 | 2020 | 1268 | 0.210 |
Why?
|
CHARGE Syndrome | 1 | 2023 | 8 | 0.210 |
Why?
|
Cord Blood Stem Cell Transplantation | 1 | 2023 | 47 | 0.210 |
Why?
|
Arthritis | 2 | 2020 | 81 | 0.200 |
Why?
|
Colitis | 1 | 2024 | 151 | 0.200 |
Why?
|
Developmental Disabilities | 2 | 2025 | 702 | 0.200 |
Why?
|
Tumor Suppressor Proteins | 1 | 2025 | 467 | 0.190 |
Why?
|
DNA-Binding Proteins | 4 | 2025 | 2055 | 0.190 |
Why?
|
Nonsense Mediated mRNA Decay | 2 | 2018 | 29 | 0.190 |
Why?
|
Disease Susceptibility | 2 | 2021 | 297 | 0.190 |
Why?
|
DNA Damage | 3 | 2020 | 512 | 0.190 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
Mutation, Missense | 3 | 2020 | 849 | 0.180 |
Why?
|
Adolescent | 13 | 2025 | 19094 | 0.180 |
Why?
|
Homozygote | 2 | 2020 | 532 | 0.180 |
Why?
|
Minichromosome Maintenance Proteins | 1 | 2020 | 9 | 0.180 |
Why?
|
Lymphopenia | 1 | 2021 | 36 | 0.180 |
Why?
|
GTP-Binding Proteins | 1 | 2021 | 171 | 0.180 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2020 | 18 | 0.180 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2021 | 140 | 0.180 |
Why?
|
Mechanistic Target of Rapamycin Complex 2 | 1 | 2020 | 28 | 0.180 |
Why?
|
DNA Copy Number Variations | 3 | 2021 | 940 | 0.180 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 1752 | 0.170 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 153 | 0.170 |
Why?
|
X-Linked Combined Immunodeficiency Diseases | 1 | 2020 | 2 | 0.170 |
Why?
|
Magnesium Deficiency | 1 | 2020 | 10 | 0.170 |
Why?
|
Sepsis | 2 | 2021 | 476 | 0.170 |
Why?
|
Autoimmune Lymphoproliferative Syndrome | 1 | 2020 | 6 | 0.170 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2019 | 31 | 0.170 |
Why?
|
Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2019 | 25 | 0.170 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 151 | 0.170 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2021 | 151 | 0.160 |
Why?
|
Actin-Related Protein 2-3 Complex | 1 | 2019 | 11 | 0.160 |
Why?
|
Infant, Newborn | 6 | 2022 | 8106 | 0.160 |
Why?
|
Immunologic Memory | 1 | 2020 | 184 | 0.160 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 279 | 0.160 |
Why?
|
Cell Differentiation | 4 | 2021 | 1909 | 0.160 |
Why?
|
Cell Line | 5 | 2024 | 2771 | 0.160 |
Why?
|
Chromosomal Instability | 1 | 2019 | 58 | 0.160 |
Why?
|
Lymphopoiesis | 2 | 2021 | 10 | 0.160 |
Why?
|
Whole Genome Sequencing | 1 | 2020 | 281 | 0.160 |
Why?
|
Guanylate Cyclase | 1 | 2018 | 37 | 0.150 |
Why?
|
Biliary Tract Diseases | 1 | 2018 | 34 | 0.150 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2018 | 43 | 0.150 |
Why?
|
Osteochondrodysplasias | 1 | 2019 | 68 | 0.150 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 67 | 0.150 |
Why?
|
Musculoskeletal Abnormalities | 1 | 2019 | 72 | 0.150 |
Why?
|
Immune System Diseases | 1 | 2018 | 43 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 1876 | 0.150 |
Why?
|
Alemtuzumab | 1 | 2018 | 88 | 0.150 |
Why?
|
Immunological Synapses | 1 | 2018 | 26 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 548 | 0.150 |
Why?
|
Chromatin | 1 | 2021 | 554 | 0.150 |
Why?
|
Data Interpretation, Statistical | 1 | 2018 | 228 | 0.140 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 74 | 0.140 |
Why?
|
Molecular Chaperones | 1 | 2018 | 167 | 0.140 |
Why?
|
Viremia | 1 | 2018 | 126 | 0.140 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 136 | 0.140 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2021 | 489 | 0.140 |
Why?
|
Trans-Activators | 1 | 2021 | 809 | 0.140 |
Why?
|
Models, Immunological | 2 | 2020 | 35 | 0.140 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2018 | 555 | 0.140 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2018 | 263 | 0.140 |
Why?
|
Interferon Regulatory Factors | 1 | 2016 | 38 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2014 | 60 | 0.140 |
Why?
|
NF-kappa B | 1 | 2019 | 457 | 0.130 |
Why?
|
Microscopy, Confocal | 1 | 2018 | 348 | 0.130 |
Why?
|
Lymphoma | 1 | 2019 | 324 | 0.130 |
Why?
|
Immunoglobulins | 1 | 2016 | 169 | 0.130 |
Why?
|
Neurodevelopmental Disorders | 1 | 2021 | 492 | 0.130 |
Why?
|
Coatomer Protein | 1 | 2016 | 31 | 0.130 |
Why?
|
Chromosome Breakage | 1 | 2016 | 168 | 0.130 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2016 | 141 | 0.130 |
Why?
|
Lung Diseases | 2 | 2016 | 378 | 0.130 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 684 | 0.130 |
Why?
|
Computational Biology | 1 | 2020 | 804 | 0.130 |
Why?
|
Cells, Cultured | 2 | 2019 | 3040 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 472 | 0.120 |
Why?
|
Codon, Nonsense | 3 | 2021 | 131 | 0.120 |
Why?
|
Animals | 10 | 2023 | 33793 | 0.120 |
Why?
|
Young Adult | 8 | 2025 | 8856 | 0.120 |
Why?
|
Genetic Variation | 2 | 2019 | 1479 | 0.120 |
Why?
|
Pyrazoles | 1 | 2017 | 304 | 0.120 |
Why?
|
HEK293 Cells | 3 | 2025 | 741 | 0.120 |
Why?
|
Virus Diseases | 2 | 2016 | 279 | 0.120 |
Why?
|
Autophagy | 1 | 2018 | 390 | 0.120 |
Why?
|
Janus Kinase 1 | 2 | 2025 | 14 | 0.120 |
Why?
|
Transcription Factors | 2 | 2022 | 2585 | 0.120 |
Why?
|
Liver Diseases | 1 | 2018 | 363 | 0.120 |
Why?
|
Cytokines | 1 | 2020 | 1284 | 0.120 |
Why?
|
Syndrome | 4 | 2021 | 1115 | 0.110 |
Why?
|
Adult | 10 | 2021 | 29010 | 0.110 |
Why?
|
Chromosome Deletion | 2 | 2023 | 638 | 0.110 |
Why?
|
Intellectual Disability | 1 | 2021 | 1047 | 0.110 |
Why?
|
Heart Defects, Congenital | 2 | 2023 | 1804 | 0.110 |
Why?
|
Neonatal Screening | 1 | 2015 | 184 | 0.110 |
Why?
|
Epilepsy | 1 | 2021 | 858 | 0.110 |
Why?
|
Parents | 2 | 2011 | 1033 | 0.110 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2013 | 14 | 0.110 |
Why?
|
Clone Cells | 1 | 2013 | 163 | 0.110 |
Why?
|
Inflammation | 4 | 2024 | 1403 | 0.100 |
Why?
|
Amino Acid Substitution | 3 | 2020 | 393 | 0.100 |
Why?
|
Signal Transduction | 2 | 2023 | 4494 | 0.100 |
Why?
|
Cohort Studies | 2 | 2021 | 4700 | 0.100 |
Why?
|
Abnormalities, Multiple | 2 | 2016 | 962 | 0.100 |
Why?
|
Postoperative Period | 1 | 2013 | 331 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2012 | 95 | 0.100 |
Why?
|
Cell Cycle Proteins | 1 | 2016 | 643 | 0.100 |
Why?
|
Asthma | 1 | 2019 | 744 | 0.100 |
Why?
|
Autoimmunity | 2 | 2024 | 172 | 0.100 |
Why?
|
Risk Assessment | 1 | 2021 | 3327 | 0.100 |
Why?
|
Cell Lineage | 1 | 2013 | 340 | 0.090 |
Why?
|
Genes, MHC Class II | 1 | 2011 | 33 | 0.090 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2013 | 216 | 0.090 |
Why?
|
Mice | 7 | 2023 | 17538 | 0.090 |
Why?
|
Family | 3 | 2020 | 571 | 0.090 |
Why?
|
Pseudolymphoma | 1 | 2010 | 4 | 0.090 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2010 | 39 | 0.090 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 1638 | 0.090 |
Why?
|
Risk Factors | 3 | 2021 | 10022 | 0.090 |
Why?
|
BRCA2 Protein | 1 | 2010 | 43 | 0.090 |
Why?
|
T-Lymphocytes | 4 | 2025 | 1690 | 0.090 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2010 | 79 | 0.090 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2010 | 102 | 0.090 |
Why?
|
Bone Marrow | 1 | 2012 | 324 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2011 | 145 | 0.090 |
Why?
|
Histocompatibility Testing | 1 | 2010 | 148 | 0.090 |
Why?
|
Binding Sites | 2 | 2025 | 1292 | 0.080 |
Why?
|
Prognosis | 1 | 2018 | 4512 | 0.080 |
Why?
|
Chromosomes | 2 | 2023 | 199 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2012 | 372 | 0.080 |
Why?
|
Models, Animal | 1 | 2011 | 464 | 0.080 |
Why?
|
Protein Binding | 2 | 2025 | 1741 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2022 | 213 | 0.080 |
Why?
|
Graft Survival | 1 | 2010 | 525 | 0.080 |
Why?
|
DNA Replication | 2 | 2022 | 350 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 2524 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2021 | 3235 | 0.070 |
Why?
|
Oxidative Stress | 1 | 2012 | 795 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2019 | 3722 | 0.060 |
Why?
|
Tissue Donors | 2 | 2007 | 496 | 0.060 |
Why?
|
Neoplasms | 1 | 2019 | 2755 | 0.060 |
Why?
|
Zinc Fingers | 1 | 2025 | 119 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2020 | 12119 | 0.060 |
Why?
|
United States | 1 | 2019 | 10653 | 0.060 |
Why?
|
Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 8 | 0.050 |
Why?
|
Busulfan | 1 | 2023 | 44 | 0.050 |
Why?
|
Fibroblasts | 2 | 2019 | 880 | 0.050 |
Why?
|
Biological Variation, Population | 1 | 2023 | 25 | 0.050 |
Why?
|
Herpesviridae Infections | 1 | 2023 | 142 | 0.050 |
Why?
|
Exome | 2 | 2018 | 1040 | 0.050 |
Why?
|
Genotype | 2 | 2019 | 2533 | 0.050 |
Why?
|
Liver | 1 | 2009 | 1734 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 2055 | 0.050 |
Why?
|
Tumor Necrosis Factor alpha-Induced Protein 3 | 1 | 2021 | 10 | 0.050 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2021 | 13 | 0.050 |
Why?
|
Blood Platelets | 1 | 2024 | 333 | 0.050 |
Why?
|
Cell Proliferation | 2 | 2020 | 2307 | 0.050 |
Why?
|
Cell Division | 1 | 2022 | 780 | 0.050 |
Why?
|
Histones | 1 | 2025 | 527 | 0.050 |
Why?
|
Cyclophosphamide | 1 | 2023 | 422 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2025 | 448 | 0.050 |
Why?
|
Consanguinity | 1 | 2021 | 104 | 0.040 |
Why?
|
Joints | 1 | 2020 | 23 | 0.040 |
Why?
|
Wiskott-Aldrich Syndrome Protein Family | 1 | 2020 | 7 | 0.040 |
Why?
|
ADP-Ribosylation Factor 1 | 1 | 2020 | 7 | 0.040 |
Why?
|
Cytidine Deaminase | 1 | 2020 | 31 | 0.040 |
Why?
|
Cell Cycle Checkpoints | 1 | 2020 | 54 | 0.040 |
Why?
|
Uniparental Disomy | 1 | 2021 | 49 | 0.040 |
Why?
|
Immunity | 1 | 2021 | 180 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2021 | 117 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2025 | 2695 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 314 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 2020 | 13 | 0.040 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 171 | 0.040 |
Why?
|
India | 1 | 2020 | 217 | 0.040 |
Why?
|
Loss of Function Mutation | 1 | 2021 | 142 | 0.040 |
Why?
|
Glycosylation | 1 | 2020 | 114 | 0.040 |
Why?
|
Proteome | 1 | 2021 | 236 | 0.040 |
Why?
|
Bayes Theorem | 1 | 2021 | 280 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2020 | 355 | 0.040 |
Why?
|
Molecular Conformation | 1 | 2019 | 100 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2020 | 350 | 0.040 |
Why?
|
Biomarkers | 2 | 2020 | 2943 | 0.040 |
Why?
|
Hematopoiesis | 1 | 2021 | 217 | 0.040 |
Why?
|
Cation Transport Proteins | 1 | 2020 | 96 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2021 | 499 | 0.040 |
Why?
|
ROC Curve | 1 | 2021 | 558 | 0.040 |
Why?
|
Candidiasis, Chronic Mucocutaneous | 1 | 2018 | 5 | 0.040 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 190 | 0.040 |
Why?
|
Autophagy-Related Protein-1 Homolog | 1 | 2018 | 9 | 0.040 |
Why?
|
Machine Learning | 1 | 2021 | 221 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2021 | 403 | 0.040 |
Why?
|
DNA Methylation | 1 | 2025 | 989 | 0.040 |
Why?
|
Chimerism | 1 | 2018 | 28 | 0.040 |
Why?
|
Models, Statistical | 1 | 2021 | 470 | 0.040 |
Why?
|
Ferritins | 1 | 2018 | 96 | 0.040 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 280 | 0.040 |
Why?
|
Guillain-Barre Syndrome | 1 | 2018 | 28 | 0.040 |
Why?
|
Unfolded Protein Response | 1 | 2018 | 62 | 0.040 |
Why?
|
Pancytopenia | 1 | 2018 | 40 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 317 | 0.040 |
Why?
|
Time Factors | 2 | 2007 | 6221 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2018 | 197 | 0.040 |
Why?
|
Unrelated Donors | 1 | 2018 | 82 | 0.040 |
Why?
|
Gene Deletion | 1 | 2021 | 792 | 0.040 |
Why?
|
Mutant Proteins | 1 | 2018 | 112 | 0.040 |
Why?
|
Antigens, CD | 1 | 2020 | 420 | 0.040 |
Why?
|
Interferon Type I | 1 | 2018 | 107 | 0.040 |
Why?
|
Janus Kinases | 1 | 2017 | 31 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 238 | 0.040 |
Why?
|
Artificial Intelligence | 1 | 2021 | 239 | 0.040 |
Why?
|
Crohn Disease | 1 | 2021 | 281 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2018 | 175 | 0.040 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2018 | 120 | 0.040 |
Why?
|
Multiple Organ Failure | 1 | 2018 | 140 | 0.030 |
Why?
|
CD56 Antigen | 1 | 2016 | 26 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 533 | 0.030 |
Why?
|
Nitriles | 1 | 2017 | 145 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2018 | 261 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2016 | 126 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 1237 | 0.030 |
Why?
|
Immunosuppressive Agents | 1 | 2020 | 642 | 0.030 |
Why?
|
Immunomodulation | 1 | 2016 | 81 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2018 | 790 | 0.030 |
Why?
|
Phosphorylation | 1 | 2020 | 1610 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 996 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 2016 | 15 | 0.030 |
Why?
|
Chromosome Segregation | 1 | 2016 | 62 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2016 | 69 | 0.030 |
Why?
|
Zebrafish | 1 | 2019 | 386 | 0.030 |
Why?
|
Cause of Death | 1 | 2018 | 462 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2016 | 58 | 0.030 |
Why?
|
Stem Cells | 1 | 2021 | 701 | 0.030 |
Why?
|
Meiosis | 1 | 2016 | 115 | 0.030 |
Why?
|
B-Lymphocyte Subsets | 1 | 2016 | 21 | 0.030 |
Why?
|
Models, Molecular | 1 | 2019 | 1070 | 0.030 |
Why?
|
Seizures | 1 | 2021 | 873 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2018 | 470 | 0.030 |
Why?
|
Mitosis | 1 | 2016 | 238 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2018 | 769 | 0.030 |
Why?
|
Exons | 1 | 2018 | 794 | 0.030 |
Why?
|
Family Health | 1 | 2016 | 259 | 0.030 |
Why?
|
Recombination, Genetic | 1 | 2016 | 446 | 0.030 |
Why?
|
Pyrimidines | 1 | 2017 | 375 | 0.030 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2014 | 13 | 0.030 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 1 | 2014 | 11 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2021 | 710 | 0.030 |
Why?
|
Complementarity Determining Regions | 1 | 2014 | 25 | 0.030 |
Why?
|
Base Sequence | 1 | 2018 | 3091 | 0.030 |
Why?
|
Prospective Studies | 2 | 2023 | 6028 | 0.030 |
Why?
|
DNA Repair | 1 | 2016 | 579 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 622 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 3291 | 0.030 |
Why?
|
Disease Progression | 1 | 2018 | 2028 | 0.030 |
Why?
|
Texas | 1 | 2021 | 3565 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2016 | 478 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2018 | 2809 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2014 | 544 | 0.020 |
Why?
|
Incidence | 1 | 2018 | 3039 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2021 | 4284 | 0.020 |
Why?
|
Cell Separation | 1 | 2010 | 231 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 1258 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2018 | 5039 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2010 | 376 | 0.020 |
Why?
|
Aged | 2 | 2016 | 19101 | 0.020 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 65 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2010 | 803 | 0.020 |
Why?
|
Skin | 1 | 2010 | 505 | 0.020 |
Why?
|
HLA Antigens | 1 | 2008 | 243 | 0.020 |
Why?
|
Middle Aged | 2 | 2016 | 26002 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2007 | 246 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 1004 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2018 | 16050 | 0.020 |
Why?
|
Survival Analysis | 1 | 2007 | 1473 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 1236 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1980 | 630 | 0.010 |
Why?
|
Herpes Zoster | 1 | 1980 | 23 | 0.000 |
Why?
|
Herpes Simplex | 1 | 1980 | 56 | 0.000 |
Why?
|
Graft Rejection | 1 | 1980 | 582 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1980 | 1138 | 0.000 |
Why?
|